| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +425K | 27.7% | $20.55 | +$8.73M |
| Sells | 12 | -1.11M | 72.3% | $31.11 | -$34.5M |
| Net | -11 | -685K | -44.6% | -$25.8M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael Morrissey | President and CEO, Director | $132M | Mar 31, 2025 | ||
| Christopher J. Senner | EVP and CFO | $39.3M | -$4.46M | -10.2% | Mar 31, 2025 |
| David Edward Johnson | Director | $32M | +$8.73M | +37.5% | May 31, 2024 |
| Jeffrey Hessekiel | EVP & General Counsel | $29.2M | -$7.87M | -21.2% | Mar 31, 2025 |
| Dana Aftab | CSO/EVP Disc & Trans Research | $27.2M | -$7.36M | -21.3% | Mar 31, 2025 |
| Stelios Papadopoulos | Director | $26.6M | -$240K | -0.9% | May 31, 2024 |
| Patrick J. Haley | EVP, Commercial | $20.7M | -$4.47M | -17.7% | Mar 31, 2025 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | $19.7M | Mar 31, 2025 | ||
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | $16.1M | Jul 26, 2021 | ||
| Jack L. Wyszomierski | Director | $13.5M | -$747K | -5.25% | Feb 28, 2025 |
| Peter Lamb | EVP, Scientific Strategy & CSO | $9.79M | Dec 15, 2022 | ||
| Lance Willsey | Director | $9.7M | May 26, 2022 | ||
| Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | $7.03M | Apr 3, 2023 | ||
| Charles Cohen | Director | $5.98M | Dec 31, 2021 | ||
| George Poste | Director | $5.87M | -$2.72M | -31.7% | Feb 14, 2025 |
| Maria C. Freire | Director | $3.18M | -$1.76M | -35.6% | Feb 14, 2025 |
| Vincent T. Marchesi | Director | $2.15M | May 26, 2022 | ||
| Bob Oliver | Director | $1.25M | -$695K | -35.7% | Feb 25, 2025 |
| Jacqueline Wright | Director | $1.18M | Jun 1, 2023 | ||
| Sue Gail Eckhardt | Director | $1.07M | -$405K | -27.5% | Feb 14, 2025 |
| Mary C. Beckerle | Director | $1.06M | -$426K | -28.6% | Feb 14, 2025 |
| Alan M. Garber | Director | $857K | Mar 21, 2024 | ||
| Tomas J. Heyman | Director | $768K | May 31, 2024 | ||
| Carl B. Feldbaum | Director | $428K | Feb 9, 2023 | ||
| Julie Smith | Director | $405K | -$3.38M | -89.3% | Feb 27, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|